Adaptimmune Therapeutics PLC 10-K for FY2022
Adaptimmune Therapeutics PLC (ADAPY)
10-K
2023-03-06
For: 2022-12-31
View Original
Added on
June 11, 2026
About this 10-K
Adaptimmune Therapeutics PLC filed this 10-K on March 6, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $27.15M
- up 341.5% from $6.15M a year earlier
- Net loss
- $165.46M
- compared with a net loss of $158.09M a year earlier
- Diluted EPS
- -$0.17
- compared with -$0.17 a year earlier